Slides and webcasts from ESMO Virtual Plenaries are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
Real-world Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Chemotherapy in First-line PDL1-high Non-squamous Lung Cancer
- Start date
- 08 Apr 2021
- End date
- 09 Apr 2021
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.
Programme
Thursday 8 April
Welcome and introduction, Scientific background and context
Natasha Leighl, Princess Margaret Cancer Centre, Toronto, ON, Canada
Real world effectiveness of PD-(L)1 inhibitors alone or in combination with chemotherapy in first-line PDL1-high non-squamous lung cancer
Solange Peters, Centre Hospitalier Universitaire Vaudois – CHUV, Lausanne, Switzerland
Critical analysis and perspectives
Federico Cappuzzo, Istituto Nazionale Tumori Regina Elena, Rome, Italy
Live discussion and Q&A
Faculty and online audience (via chat feature)
Friday 9 April
Webcast of the ESMO Virtual Plenary plus additional live Discussion and Q&A with Faculty and online audience (via chat feature)
Solange Peters, Centre Hospitalier Universitaire Vaudois – CHUV, Lausanne, Switzerland
Federico Cappuzzo, Istituto Nazionale Tumori Regina Elena, Rome, Italy
Tony SK Mok, Prince of Wales Hospital, Hong Kong, China
Dong-Wan Kim, Seoul National University Hospital, Seoul, Republic of Korea
Daniel Tan, National Cancer Centre Singapore, Singapore
